| 1 | 1373175 | Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. | J Neurochem | 1992 May |
1 |
| 2 | 9143251 | Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. | J Neuroimmunol | 1997 May |
5 |
| 3 | 10064079 | Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. | Eur J Immunol | 1999 Feb |
1 |
| 4 | 10741394 | Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. | Eur J Immunol | 2000 Mar |
1 |
| 5 | 11122253 | The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. | Clin Exp Immunol | 2000 Dec |
1 |
| 6 | 11311328 | Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. | J Neuroimmunol | 2001 May 1 |
2 |
| 7 | 11390514 | Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. | J Immunol | 2001 Jun 15 |
1 |
| 8 | 11438174 | Brain-derived gangliosides suppress the chronic relapsing-remitting experimental autoimmune encephalomyelitis in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. | J Neuroimmunol | 2001 Jun 1 |
3 |
| 9 | 12023389 | Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression. | J Immunol | 2002 Jun 1 |
1 |
| 10 | 12112074 | Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. | Ann Neurol | 2002 Jun |
1 |
| 11 | 12395089 | Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. | Neuroreport | 2002 Oct 28 |
1 |
| 12 | 12778471 | Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis. | Eur J Immunol | 2003 Jun |
1 |
| 13 | 12926537 | Post intoxicative therapeutic immunization with myelin oligodendrocyte glycoproteine (MOG 35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with 1-methyl-4 phenyl-1,2,3,6-tetrahydropiridine (MPTP). | Acta Neurobiol Exp (Wars) | 2003 |
2 |
| 14 | 14556941 | Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. | Brain Res | 2003 Nov 7 |
2 |
| 15 | 14768043 | An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. | Eur J Immunol | 2004 Feb |
1 |
| 16 | 15051763 | Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. | J Exp Med | 2004 Apr 5 |
1 |
| 17 | 15081244 | A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. | J Neuroimmunol | 2004 May |
2 |
| 18 | 15147517 | A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. | J Neurochem | 2004 Jun |
1 |
| 19 | 15210763 | The third signal in T cell-mediated autoimmune disease? | J Immunol | 2004 Jul 1 |
2 |
| 20 | 15680707 | Immunization with myelin oligodendrocyte glycoprotein and complete Freund adjuvant partially protects dopaminergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease. | Neuroscience | 2005 |
1 |
| 21 | 15681762 | Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies. | Ann N Y Acad Sci | 2004 Dec |
3 |
| 22 | 16055951 | Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant. | J Mol Neurosci | 2005 |
5 |
| 23 | 16098614 | Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. | J Neuroimmunol | 2005 Nov |
2 |
| 24 | 16426494 | FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. | Cell Mol Immunol | 2005 Dec |
1 |
| 25 | 16835249 | Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. | Brain | 2006 Aug |
4 |
| 26 | 16914558 | A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. | J Pharmacol Exp Ther | 2006 Nov |
2 |
| 27 | 17056528 | IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. | J Immunol | 2006 Nov 1 |
3 |
| 28 | 17202353 | Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. | J Immunol | 2007 Jan 15 |
1 |
| 29 | 17523133 | Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity. | Eur J Immunol | 2007 Jul |
1 |
| 30 | 17579036 | I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis. | J Immunol | 2007 Jul 1 |
1 |
| 31 | 17654737 | Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine. | Ann Neurol | 2007 Jul |
2 |
| 32 | 18303055 | Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis. | Glycobiology | 2008 May |
3 |
| 33 | 18320716 | Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration. | Acta Neurobiol Exp (Wars) | 2007 |
11 |
| 34 | 18485368 | Phenytoin protects central axons in experimental autoimmune encephalomyelitis. | J Neurol Sci | 2008 Nov 15 |
2 |
| 35 | 18568646 | Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. | Autoimmunity | 2008 Aug |
3 |
| 36 | 18678605 | Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. | J Leukoc Biol | 2008 Oct |
1 |
| 37 | 18773080 | A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. | PLoS One | 2008 Sep 5 |
4 |
| 38 | 19188909 | Anaphylaxis to a self-peptide in the absence of mast cells or histamine. | Lab Invest | 2009 Apr |
3 |
| 39 | 19234156 | Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine. | J Immunol | 2009 Mar 1 |
1 |
| 40 | 19257986 | [Suppression of murine EAE by triptolide is related to downregulation of INF-gamma and upregulation of IL-10 secretion in splenic lymphocytes]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2009 Mar |
1 |
| 41 | 19286483 | Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease. | Int Immunopharmacol | 2009 Jun |
3 |
| 42 | 19654226 | Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and Peloruside A. | J Leukoc Biol | 2009 Oct |
1 |
| 43 | 19659692 | Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes. | J Neurochem | 2009 Oct |
1 |
| 44 | 19855075 | Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. | Exp Biol Med (Maywood) | 2009 Nov |
2 |
| 45 | 19879252 | Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. | Brain Res | 2010 Jan 14 |
2 |
| 46 | 19879259 | B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. | Exp Neurol | 2010 Jan |
2 |
| 47 | 19965930 | Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis. | Mol Endocrinol | 2010 Feb |
2 |
| 48 | 20077431 | Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. | J Neurosci Res | 2010 Jun |
2 |
| 49 | 20399559 | A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). | Pain | 2010 Jun |
2 |
| 50 | 20955831 | Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis. | Int Immunopharmacol | 2011 Mar |
1 |